Pfizer and Moderna to expand size of vaccine studies in 5- to 11-year-olds
MarsBars/iStock (LOS ANGELES) - Pfizer and Moderna are expanding the size of their COVID-19 vaccine studies in children ages 5 to 11, according to a new report. The decision, which…